PALO ALTO, Calif., May 16 /PRNewswire-FirstCall/ -- Affymax, Inc. today announced that Arlene M. Morris, the company's president and chief executive officer, will present at the 2007 Citi Global Healthcare Conference on Wednesday, May 23, at 2:30 p.m. Eastern Time at The Hilton New York.
A live webcast of the presentation will be available on the Investors section of the company's website at www.affymax.com. A replay will also be available for 30 days following the presentation.
About Affymax, Inc.
Affymax, Inc. is a biopharmaceutical company developing novel peptide- based drugs to improve the treatment of serious and often life-threatening conditions. Affymax's lead product candidate, Hematide(TM), is currently in Phase 2 clinical trials for the treatment of anemia associated with chronic kidney disease and cancer. For additional information, please visit www.affymax.com.
Affymax, Inc.CONTACT: Sylvia Wheeler, Executive Director, Investor Relations ofAffymax, Inc., +1-650-812-8861
Web site: http://www.affymax.com//
